| CXC Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes T Andersen, T Ueland, T Ghukasyan Lakic, A Åkerblom, M Bertilsson, ... Arteriosclerosis, thrombosis, and vascular biology 39 (11), 2402-2410, 2019 | 27 | 2019 |
| Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial F Kontny, T Andersen, T Ueland, A Åkerblom, TG Lakic, AE Michelsen, ... European Heart Journal: Acute Cardiovascular Care 9 (4), 313-322, 2020 | 17 | 2020 |
| Procollagen Type 1 N-terminal Propeptide, a Collagen Synthesis Biomarker, is Associated With Adverse Clinical Outcome in Patients With Suspected Acute Coronary Syndrome T Andersen, DW Nilsen, H Grundt, H Staines, T Ueland, P Aukrust, ... Circulation 144 (Suppl_1), A12013-A12013, 2021 | 1 | 2021 |
| The Novel Wnt-Pathway Inhibitor Podocan is Not Associated with All-Cause Mortality or Cardiovascular Outcome in Patients Admitted with Suspected Acute Coronary Syndrome T Andersen, DW Nilsen, H Grundt, H Staines, T Ueland, P Aukrust, ... Circulation 144 (Suppl_1), A9149-A9149, 2021 | 1 | 2021 |
| Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes T Andersen, T Ueland, P Aukrust, DW Nilsen, H Grundt, H Staines, ... Frontiers in Cardiovascular Medicine, 1195, 0 | | |
Stefan JamesUppsala University在 ucr.uu.se 的电子邮件经过验证
Stefan JamesUppsala University在 ucr.uu.se 的电子邮件经过验证
Lars WallentinSenior professor cardiology, Uppsala Universitet在 ucr.uu.se 的电子邮件经过验证
Robert F StoreyUniversity of Sheffield在 sheffield.ac.uk 的电子邮件经过验证